Psoriatic Arthritis [clinicaltrials_resource:7dc7f2cc03359f1f38c897b5031addf1]
Study of Psoriatic Arthritis [clinicaltrials:NCT00001420]clinicaltrials:NCT00023205Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis [clinicaltrials:NCT00051662]clinicaltrials:NCT00127842TNFalfa Blocking Treatment of Spondylarthropathies [clinicaltrials:NCT00133315]Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis [clinicaltrials:NCT00195689]Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) [clinicaltrials:NCT00235885]clinicaltrials:NCT00245960clinicaltrials:NCT00267956Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis [clinicaltrials:NCT00317499]A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM) [clinicaltrials:NCT00427362]Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis [clinicaltrials:NCT00432406]Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment [clinicaltrials:NCT00451243]Phase II Study With CC-10004 in Psoriatic Arthritis [clinicaltrials:NCT00456092]clinicaltrials:NCT00462072Rituxan With or Without Methotrexate in Psoriatic Arthritis [clinicaltrials:NCT00509678]Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy [clinicaltrials:NCT00517101]clinicaltrials:NCT00534313Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis [clinicaltrials:NCT00580632]A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector [clinicaltrials:NCT00643526]clinicaltrials:NCT00659412Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia [clinicaltrials:NCT00751387]Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis [clinicaltrials:NCT00809614]Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis [clinicaltrials:NCT00884468]Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment [clinicaltrials:NCT00902005]To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions [clinicaltrials:NCT00946686]A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis [clinicaltrials:NCT00963313]T Cells and TNF: The Impact of TNF Blockade [clinicaltrials:NCT01060098]A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis [clinicaltrials:NCT01078558]Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine [clinicaltrials:NCT01078610]clinicaltrials:NCT01083121clinicaltrials:NCT01083693clinicaltrials:NCT01106079clinicaltrials:NCT01111240National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study [clinicaltrials:NCT01123265]Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis [clinicaltrials:NCT01139918]clinicaltrials:NCT01147874clinicaltrials:NCT01163916Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis [clinicaltrials:NCT01169844]clinicaltrials:NCT01172938
condition [clinicaltrials_vocabulary:condition]
Psoriatic Arthritis [clinicaltrials_resource:7dc7f2cc03359f1f38c897b5031addf1]
Bio2RDF identifier
7dc7f2cc03359f1f38c897b5031addf1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7dc7f2cc03359f1f38c897b5031addf1
identifier
clinicaltrials_resource:7dc7f2cc03359f1f38c897b5031addf1
title
Psoriatic Arthritis
@en
label
Psoriatic Arthritis [clinicaltrials_resource:7dc7f2cc03359f1f38c897b5031addf1]
@en